Diagnostic Value of Qualitative and Quantitative Contrast-Enhanced Ultrasound for Pathological Subtypes of Small Solid Renal Masses
- PMID: 36591796
- DOI: 10.1002/jum.16169
Diagnostic Value of Qualitative and Quantitative Contrast-Enhanced Ultrasound for Pathological Subtypes of Small Solid Renal Masses
Abstract
Objectives: To assess the diagnostic value of qualitative and quantitative contrast-enhanced ultrasound (CEUS) for pathological subtypes of small solid renal masses (sSRMs).
Methods: Patients with sSRMs confirmed by surgical pathology from January 2019 to November 2021 were retrospectively identified. All patients were divided into 3 groups: clear cell renal cell carcinoma (ccRCC) group, none-ccRCC group (renal cell carcinoma other than ccRCC), and angiomyolipoma (AML) group. The mass position, size, echogenicity and blood flow signals were compared. The speed of wash-in, wash-out, the degree of peak enhancement and the homogeneity at peak enhancement, the presence of pseudocapsule sign in CEUS imaging were qualitatively evaluated. Peak enhancement, wash-in area under the curve (WiAUC), rise time, time to peak, wash-in rate (WiR), wash-in perfusion index (WiPI) and tumor-to-cortex enhancement ratio of the above parameters in CEUS imaging were quantitatively evaluated.
Results: Of 105 patients, 105 sSRMs (66 ccRCC, 18 none-ccRCC, 21 AML) were enrolled in this study. No significant differences were found on location, size and echogenicity among 3 groups (all P > .05). The proportion of fast-washout and hypo-enhancement were highest in none-ccRCC group. Heterogeneous enhancement was detected in 87.88% in ccRCC group which is significantly higher than other 2 groups. Hundred percent of the AML showed no pseudocapsule sign, which is the highest among the 3 groups. Peak enhancement, WiAUC, WiR, WiPI of ccRCC group were the highest among the 3 groups.
Conclusions: Qualitative and quantitative CEUS not only has the diagnostic value in distinguishing AML from malignant sSRMs, but also helps to differentiate the pathological subtypes of sSRMs.
Keywords: angiomyolipoma; contrast-enhanced ultrasound; renal cell carcinoma; small solid renal masses.
© 2023 American Institute of Ultrasound in Medicine.
Similar articles
-
High-frame-rate contrast-enhanced ultrasound to differentiate between clear cell renal cell carcinoma and angiomyolipoma.BMC Cancer. 2024 May 30;24(1):659. doi: 10.1186/s12885-024-12413-4. BMC Cancer. 2024. PMID: 38816725 Free PMC article.
-
Triphasic and epithelioid minimal fat renal angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative CEUS characteristics and distinguishing features.Abdom Imaging. 2015 Feb;40(2):333-42. doi: 10.1007/s00261-014-0221-y. Abdom Imaging. 2015. PMID: 25139641
-
Role of Contrast-Enhanced Ultrasound With the Enhancement Pattern and Qualitative Analysis for Differentiating Hypovascular Solid Renal Lesions.Ultrasound Med Biol. 2024 Feb;50(2):295-303. doi: 10.1016/j.ultrasmedbio.2023.11.002. Epub 2023 Nov 23. Ultrasound Med Biol. 2024. PMID: 37996360
-
Qualitative and quantitative characteristics of CEUS for renal cell carcinoma and angiomyolipoma: a narrative review.J Ultrasound. 2024 Mar;27(1):13-20. doi: 10.1007/s40477-023-00852-x. Epub 2024 Jan 19. J Ultrasound. 2024. PMID: 38238503 Free PMC article. Review.
-
Characteristics of contrast-enhanced ultrasound for diagnosis of solid clear cell renal cell carcinomas ≤4 cm: A meta-analysis.Cancer Med. 2021 Dec;10(23):8288-8299. doi: 10.1002/cam4.4365. Epub 2021 Nov 1. Cancer Med. 2021. PMID: 34725960 Free PMC article. Review.
Cited by
-
Diagnostic Value of Contrast-Enhanced Ultrasound in Differentiating Malignant from Benign Small Renal Masses After CT/MRI.J Clin Med. 2024 Oct 29;13(21):6478. doi: 10.3390/jcm13216478. J Clin Med. 2024. PMID: 39518616 Free PMC article.
-
Qualitative and quantitative assessment of non-clear cell renal cell carcinoma using contrast-enhanced ultrasound.BMC Urol. 2024 Jun 17;24(1):129. doi: 10.1186/s12894-024-01514-8. BMC Urol. 2024. PMID: 38886684 Free PMC article.
-
Qualitative Assessment of Contrast-Enhanced Ultrasound in Differentiating Clear Cell Renal Cell Carcinoma and Oncocytoma.J Clin Med. 2023 Apr 23;12(9):3070. doi: 10.3390/jcm12093070. J Clin Med. 2023. PMID: 37176510 Free PMC article.
-
Renal cell carcinoma of the native kidney in renal transplant recipients: case report and literature review.Front Oncol. 2025 Apr 29;15:1536411. doi: 10.3389/fonc.2025.1536411. eCollection 2025. Front Oncol. 2025. PMID: 40365341 Free PMC article.
References
-
- Finelli A, Ismaila N, Bro B, et al. Management of small renal masses: American society of clinical oncology clinical practice guideline. J Clin Oncol 2017; 35:668-680.
-
- Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. World J Urol 2018; 36:1341-1353.
-
- Hakim SW, Schieda N, Hodgdon T, McInnes MD, Dilauro M, Flood TA. Angiomyolipoma (AML) without visible fat: ultrasound, CT and MR imaging features with pathological correlation. Eur Radiol 2016; 26:592-600.
-
- Cao H, Fang L, Chen L, et al. The value of contrast-enhanced ultrasound in diagnosing small renal cell carcinoma subtypes and angiomyolipoma. J Ultrasound Med 2022; 41:1415-1423.
-
- Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program. J Urol 2006; 176:2397-2400. discussion 2400.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical